𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A High-Throughput Screen for Identifying Transmembrane Pore-Forming Peptides

✍ Scribed by Joshua M. Rausch; William C. Wimley


Book ID
102559389
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
178 KB
Volume
293
Category
Article
ISSN
0003-2697

No coin nor oath required. For personal study only.

✦ Synopsis


We have developed a visual microwell plate assay for rapid, high-throughput screening for membrane-disrupting molecules such as de novo designed pore formers, antibiotic peptides, bacterial toxins, and lipases. The detectability is based on the strong fluorescence emission of the lanthanide metal terbium(III) (Tb 3؉ ) when it interacts with the aromatic chelator dipicolinic acid (DPA). While Tb 3؉ is not strongly fluorescent alone, the binary complex emits bright green fluorescence when irradiated with uv light. For the microwell plate assay, we prepared unilamellar phospholipid vesicles that had either Tb 3؉ or DPA entrapped and the opposite molecule in the external solution. Disruption of the membranes allows the Tb 3؉ /DPA complex to form, giving rise to a visibly fluorescent solution. In plates with 20-l wells, the lower limit of visual detectability of the Tb 3؉ / DPA complex in solution was about 2.5 M. The lower limit of detectability using vesicles with entrapped Tb 3؉ or DPA was about 50 M phospholipid. We show that the membrane-disrupting effect of as little as 0.25 M or 5 pmol of the pore-forming, antibiotic peptide alamethicin can be detected visually with this system. This sensitive, high-throughput assay is readily automatable and makes possible the visual screening of combinatorial peptide libraries for members that permeabilize lipid bilayer membranes.


📜 SIMILAR VOLUMES


Designed Amyloid β Peptide Fibril—A Tool
✍ Gunnar T. Dolphin; Myriam Ouberai; Pascal Dumy; Julian Garcia 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 502 KB

## Abstract Amyloid β peptide (Aβ) fibril formation is widely believed to be the causative event of Alzheimer’s disease pathogenesis. Therapeutic approaches are therefore in development that target various sites in the production and aggregation of Aβ. Herein we present a high‐throughput screening

Application of a novel in silico high-th
✍ Catherine Joce; Joshua A. Stahl; Mitesh Shridhar; Mark R. Hutchinson; Linda R. W 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 447 KB

Increasing numbers of target protein structures available for computational studies makes the structure-based screening paradigm more attractive for initial hit indentification. We have developed a novel in silico screening methodology incorporating Molecular Mechanics (MM)/implicit solvent methods